1870 companies

P&K Skin Research Center

Market Cap: ₩81.4b

Engages in the evaluation and research of dermatological products in South Korea.

A347740

₩2,780.00

7D

-4.1%

1Y

3.5%

Proteomics International Laboratories

Market Cap: AU$52.4m

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia.

PIQ

AU$0.35

7D

0%

1Y

-50.0%

JW Pharmaceutical

Market Cap: ₩497.4b

Manufactures and sells medicines and medical supplies in Japan and internationally.

A001060

₩21,150.00

7D

-5.4%

1Y

-25.9%

Yuyu Pharma

Market Cap: ₩68.4b

Develops and markets pharmaceutical products.

A000220

₩4,230.00

7D

-3.3%

1Y

-8.4%

Daiichi Sankyo Company

Market Cap: JP¥6.3t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

4568

JP¥3,344.00

7D

-5.6%

1Y

-31.3%

Zhejiang Yatai Pharmaceutical

Market Cap: CN¥4.2b

Researches, produces, sells, and exports pharmaceutical products in China and internationally.

002370

CN¥5.67

7D

-3.1%

1Y

87.7%

MedPacto

Market Cap: ₩151.5b

A drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea.

A235980

₩4,300.00

7D

-6.3%

1Y

-31.0%

Xcell Therapeutics

Market Cap: ₩34.0b

Engages in the development and production of drugs for cell therapy.

A373110

₩3,005.00

7D

-8.2%

1Y

-63.1%

Sinil Pharmaceutical

Market Cap: ₩70.4b

Manufactures and sells pharmaceutical products in South Korea and internationally.

A012790

₩6,120.00

7D

-2.1%

1Y

-16.6%

Prescient Therapeutics

Market Cap: AU$44.2m

A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.

PTX

AU$0.042

7D

-1.2%

1Y

6.4%

Cisen Pharmaceutical

Market Cap: CN¥9.2b

Research, develops, produces, and sells drug products in China and internationally.

603367

CN¥19.84

7D

-5.0%

1Y

47.9%

Sunflower Pharmaceutical GroupLtd

Market Cap: CN¥9.0b

Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.

002737

CN¥15.40

7D

-1.7%

1Y

-29.1%

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥29.2b

Engages in production, marketing, and services related to central nervous system drugs in China.

002262

CN¥27.74

7D

1.1%

1Y

11.0%

NatureCellLtd

Market Cap: ₩1.3t

Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.

A007390

₩20,200.00

7D

-3.6%

1Y

108.0%

Harbin Pharmaceutical Group

Market Cap: CN¥8.9b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

600664

CN¥3.60

7D

-1.4%

1Y

5.6%

Kringle Pharma

Market Cap: JP¥3.3b

Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.

4884

JP¥467.00

7D

-3.9%

1Y

-45.8%

GC Genome

Market Cap: ₩185.9b

Operates as a clinical genome analysis company in South Korea.

A340450

₩7,510.00

7D

-7.1%

1Y

n/a

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥12.4b

Engages in the blood product businesses in China.

300294

CN¥24.52

7D

-2.0%

1Y

-25.5%

Shanghai InnoStar Bio-tech

Market Cap: CN¥7.0b

Provides drug research and development services in China and internationally.

688710

CN¥47.39

7D

-3.6%

1Y

78.1%

Sinew Pharma

Market Cap: NT$3.4b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

6634

NT$47.40

7D

2.0%

1Y

-25.5%

Takara Bio

Market Cap: JP¥112.9b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

4974

JP¥939.00

7D

-1.5%

1Y

-9.9%

Ribomic

Market Cap: JP¥4.2b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

4591

JP¥98.00

7D

3.2%

1Y

18.1%

Kissei Pharmaceutical

Market Cap: JP¥184.4b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

4547

JP¥4,455.00

7D

0.2%

1Y

24.8%

Solasia Pharma K.K

Market Cap: JP¥9.5b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

4597

JP¥36.00

7D

0%

1Y

-23.4%

ScinoPharm Taiwan

Market Cap: NT$15.2b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

1789

NT$18.85

7D

2.4%

1Y

-25.9%

Peptron

Market Cap: ₩6.6t

Engages in the development of peptide-based medicines.

A087010

₩277,500.00

7D

-4.1%

1Y

418.7%

Alar Pharmaceuticals

Market Cap: NT$14.5b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

6785

NT$213.00

7D

0.7%

1Y

14.5%

RP Bio

Market Cap: ₩62.9b

A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.

A314140

₩7,280.00

7D

4.7%

1Y

9.5%

2invest

Market Cap: €74.4m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

2INV

€13.50

7D

7.1%

1Y

28.6%

Smart Agro -

Market Cap: ₪9.4m

Focuses on the research and development in the field of agricultural technology in Israel.

SMAG

₪2.25

7D

0%

1Y

-47.5%

Regeneron Pharmaceuticals

Market Cap: US$59.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

REGN

US$555.51

7D

-7.2%

1Y

-46.6%

Sanofi

Market Cap: €94.3b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

SAN

€77.52

7D

-3.3%

1Y

-24.2%

Pharma-Bio Serv

Market Cap: US$13.8m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

PBSV

US$0.60

7D

5.3%

1Y

9.1%

Mustang Bio

Market Cap: US$11.7m

A clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.

MBIO

US$1.60

7D

-1.2%

1Y

-86.6%

Devonian Health Group

Market Cap: CA$23.8m

Engages in the development of botanical drugs.

GSD

CA$0.14

7D

-14.7%

1Y

-6.5%

OnKure Therapeutics

Market Cap: US$34.4m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.

OKUR

US$2.54

7D

2.4%

1Y

n/a

Page 8 of 52